US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 24.370
  • +0.470+1.97%
Trading May 10 13:39 ET
201.14MMarket Cap-63629P/E (TTM)

CervoMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CervoMed Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.42

+85.89%
Analyst Rating

Buy

Apr 30, 2024

CervoMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.000M--
--2024/Q1-- / 2.350M--
--2023/Q42.491M / 1.000M--
--2023/Q31.526M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.000M--
--2024/Q1-- / 2.350M--
--2023/Q42.491M / 1.000M--
--2023/Q31.526M / 0.000--

CervoMed Earnings Reports

  • CervoMed | 10-K: Annual report

    Mar 29 16:03 ET

  • CervoMed: Q3 2023 Earnings Report

    Nov 13, 2023 06:30 ET

  • Diffusion Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:32 ET

  • Diffusion Pharmaceuticals | 10-Q: Q1 2023 Earnings Report

    May 15, 2023 08:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg